news.volyx.in

BioNTech presents positive phase 1/2 data for CAR-T cell therapy candidate (investors.biontech.de)

232 points by doener · 1034 days ago · 95 comments on HN

The AI summary for this story hasn't been generated yet — it's produced hourly. Check back soon. Meanwhile, read the discussion on HN.